iCleanse Announces UV-C Product Licensing & Distribution Partnership with ChargeTech

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

March 2, 2021

iCleanse, the leader in UV-C personal device disinfection, today announces its partnership with ChargeTech, a leader in device management solutions, to combat the spread of COVID-19, expanding iCleanse’s UV-C disinfection product market reach across the Americas, Europe, and the Middle East.

ChargeTech will license iCleanse patents for ChargeTech’s existing suite of high capacity, UV-C Clean-Charge-Store Cabinets and Carts. This alliance allows iCleanse and ChargeTech to better serve the marketplace by offering the most comprehensive suite of patented chemical-free UV-C disinfection devices to combat 99.99% of pathogens, such as COVID-19.

iCleanse is the leader in chemical-free UV-C disinfection for mobile devices and the only patented solution. iCleanse’s partnership with ChargeTech will expand its reach into new markets beyond iCleanse’s industry-leading hospital network. ChargeTech’s connections with businesses across the country, in Europe, and the Middle East will help bring awareness to the power of UV-C and the importance of regularly disinfecting mobile phones and other devices to break the virus cycle.

“We are excited to announce iCleanse’s partnership with ChargeTech,” said Chris Allen, CEO of iCleanse. “They are an exceptional company of innovators with great products themselves. There is a great opportunity for us both to get our products out there to help businesses and communities battle COVID-19.”

iCleanse Product Line to be Distributed by ChargeTech

The iCleanse product line includes the Swift XL, Swift Mini, and Swift, which are engineered to control the disinfection process and adapt to a variety of venues, such as retail stores, restaurants, airports, and more.
The iCleanse product line includes:

  • iCleanse Swift XL: a patented chemical-free UV-C disinfection product for mobile devices and other personal items that kills 99.99% of pathogens, like COVID-19, in as little as 30 seconds. The Swift XL quickly disinfects multiple mobile phones and large-sized tablets simultaneously, as well as bulkier electronics and personal items, such as body cams, CB radios, stethoscopes, hairbrushes, and more. Simple to use, it comes equipped with an easy to navigate user interface to quickly start disinfection cycles or customize cycle times. The software includes notification when it’s time to replace the UV-C lamps, ensuring that devices are always properly disinfected.
  • iCleanse Swift and Swift Mini: are similar to the original popular Swift XL disinfection unit, but with a much smaller footprint. The small Swift Mini is only 15.5 inches wide and Swift is only 20 inches wide.  The Swift and Swift Mini are much more portable and versatile for hospitals and businesses without available space to sanitize devices.

“This partnership will enable us to better serve our existing corporate clients by expanding our product offering in this critically important category,” said ChargeTech CEO John Cappetta. “We were so impressed by the design and efficacy of the iCleanse products that we decided the best way to serve our customers was to expand on our large format suite of products by adding the iCleanse line or products as one of their licensed distributors. We are thrilled to expand on our CleanCharge line of large format UV-C device charging, cleaning, and storage products with the exceptional iCleanse products.”

 

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.